Digital Health Global

JANUARY 26, 2024

NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

Drug Development 88

Drug Development Mental health Psychiatry Digital Health 88

Healthcare IT Today

MARCH 15, 2024

According to BSI’s recent Trust in AI Poll , which surveyed 10,000 adults across nine countries, including the U.S., Another recent University of Washington study found that AI spotted warning signs of mental health issues in everyday text messages at the same rate as human psychiatrists. billion by 2032.

Pharmaceuticals 94

Pharmaceuticals Drug Development Mental health Nursing 94

Health Populi

APRIL 29, 2019

As patients now assume the role of health consumer, they rationally expect retail-level experiences with greater first-dollar payment for health insurance, health care services and medical products like prescription drugs. Expanding Alexa skills to join the growing tele-mental health supply side.

HIPAA 305

HIPAA Drug Development Digital Health Mental health 305

Healthcare IT Today

JANUARY 17, 2024

Dr. Carl Marci, Chief Psychiatrist and Managing Director of Mental Health at OM1 The industry needs commitment, not hype related to AI in mental health: As we move into the new year, the industry will continue the hype-cycle around the myriad uses of AI in mental health. Carolyn Ward, M.D.

Health IT 110

Health IT Mental health Interoperability Patient Experience 110